UNSPSC 51263306: Dioxadilol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H25NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G25Z4785LV, chemically known as (- )-1-(1,4-benzodioxan-2-ylmethoxy)-3-(tert-butylamino)-2-propanol. but generally known as dioxadilol, which bears US NIH Compound Identifier 208844. European Medicines Agency schedules Dioxadilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07199MIG.

UNSPSC 51263306 Dioxadilol is a Commodity code that in recent state and local procurement activity covers naloxone and drug deactivation systems purchased by public health agencies and state health commissions. The scope spans finished pharmaceutical products and related safety equipment procured to support community health and substance-abuse intervention programs. Issuing bodies under this code include county health departments and state health and human services commissions, with activity originating from both traditional public-health procurement offices and state-level health authorities.

Recent opportunities cluster in Florida and Texas. Seminole County, Florida released IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its community health building; the response deadline was July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to solicit vendor information on direct-to-manufacturer prescription programs and pharmacy benefit capabilities, with a response deadline of April 3, 2026. The Seminole County procurement is structured as a fixed-fee, two-year initial term with one-year renewal option, includes FEMA-funding compliance requirements, and mandates workers' compensation and general liability insurance. The Texas RFI functions as preliminary market research to inform future pharmacy benefit strategy and does not carry a formal award timeline or budget allocation.